Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control

J Am Heart Assoc. 2020 Jan 7;9(1):e013531. doi: 10.1161/JAHA.119.013531. Epub 2019 Dec 31.
No abstract available

Keywords: HDL; cholesterol; diabetes mellitus; glycemic control; insulin sensitivity; β‐cell function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apolipoprotein A-I / blood
  • Biomarkers / blood
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Cholesterol / blood*
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dyslipidemias / blood*
  • Dyslipidemias / diagnosis
  • Homeostasis
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • Insulin-Secreting Cells / pathology

Substances

  • APOA1 protein, human
  • Apolipoprotein A-I
  • Biomarkers
  • Blood Glucose
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypoglycemic Agents
  • Cholesterol